Announcements from businesses shaping what comes next.
RBX2660 pivotal Phase 3 trial successfully met the primary endpoint; data presented today at Digestive Disease Week® (DDW) RBX2660 is the first microbiota-based live biotherapeutic to demonstrate efficacy as early as first recurrence of Clostridioides difficil
New analyses from pivotal BAVENCIO® study reinforce unique clinical benefits across different subgroups in the treatment of advanced urothelial carcinoma New data from VISION study of TEPMETKO® show association between liquid biopsy-identified biomarker and cl
- The positive opinion is based on the EMPEROR-Reduced trial, which showed a significant 25 percent reduction in the combined relative risk of cardiovascular death or hospitalization for heart failure - The results were observed in adults with heart failure wi
River damming, water pollution, overfishing, and sand quarrying have been damaging the living environment of aquatic organisms in the Yangtze River for some time. The decline of biodiversity in the Yangtze ecosystem is an immediate threat to fishery production,
End-to-end 5G Private Network with Open RAN capabilities, cloud-enabled 5G Core, orchestration and analytics, and an ecosystem of device and application partners Ban Chang ‘Silicon Beach’ Smart City showcasing today’s technology in partnership with 5GCT, Maven
− The Ministry of Health, Labour and Welfare (MHLW) Grants Regulatory Approval of Moderna’s COVID-19 Vaccine (COVID-19 Vaccine Moderna Intramuscular Injection) Following Positive Interim Results in Takeda’s Phase 1/2 Immunogenicity and Safety Clinical Trial − I
− If Approved, Maribavir Will Be the First and Only Treatment Indicated for Post-Transplant Cytomegalovirus (CMV) Infection in Those That Are Refractory, With or Without Resistance (R/R) − NDA based on Phase 3 Trial of Maribavir Which Met Its Primary Endpoint
What started out as a way for the style community to come together when the pandemic stopped the industry in its tracks has grown into one of the largest gatherings of the fashion industry worldwide. Now, with life opening back up in the US and abroad, Glamhive
Schlumberger announced today a collaboration with Amazon Web Services (AWS) to deploy domain centric digital solutions, enabled by the DELFI* cognitive E&P environment, on the cloud with AWS. This collaboration will bring AWS customers to the DELFI Petrotechnic
ISS Confirms Underperformance and Concern of Entrenchment Oasis Urges Shareholders to Vote on the GOLD Proxy Card for the Oasis Nominees Oasis Management Company Ltd. (“Oasis”) is manager to a fund that is a significant, long-term shareholder of Stratus Proper
Immuta, the leading provider of cloud data access control, today announced that it has secured $90 million in Series D funding. Immuta will use the investment to further its market leadership position and capture rising demand for centralized, scalable access c
Yugabyte, the leader in open source distributed SQL databases, today announced an expanded global footprint with the opening of new business operations in the EMEA and APAC regions. The international expansion is being fueled by the worldwide demand for the Yug
ComplyAdvantage, a global data technology company transforming financial crime detection, today announced a new investment by the Growth Equity team in Goldman Sachs Asset Management. The terms of the transaction were not disclosed. This press release features
NTT today announced a $3M donation to support the humanitarian tragedy facing the people of India. This brings the total combined donation from NTT and its affiliates, including NTT DATA Services and NTT Ltd, to $10M in relief aid to India. The donations will s
Senator, Dr. Rasha Kelej, CEO of Merck Foundation, the philanthropic arm of Merck KGaA Germany, together with H.E. Mrs. NEO JANE MASISI, The First Lady of Botswana and Ambassador of Merck More Than A Mother, announced the winners of “Stop GBV” Best Poster Cont